MARCOS
GONZÁLEZ DÍAZ
Ikertzailea 1993-2023 tartean
St. Joseph Medical Center
Houston, Estados UnidosSt. Joseph Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477